These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1685604)

  • 1. Very low seroprevalence of HTLV-I/II in Cuba: antibodies in blood donors and in hematological and nonhematological patients.
    Hernandez Ramirez P; Rivero Jimenez R; Ballester Santovenia M; Navea Leyva L; Matutes E; Catovsky D; Yamaguchi K; Fukuyoshi Y; Nishimura Y; Kiyokawa T
    Vox Sang; 1991; 61(4):277-8. PubMed ID: 1685604
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalence of HTLV-I and HTLV-II.
    Zanetti AR; Galli C
    N Engl J Med; 1992 Jun; 326(26):1783; author reply 1783-4. PubMed ID: 1350659
    [No Abstract]   [Full Text] [Related]  

  • 3. HTLV-I/II antibodies in French blood donors.
    Coste J; Lemaire JM; Barin F; Courouce AM
    Lancet; 1990 May; 335(8698):1167-8. PubMed ID: 1971905
    [No Abstract]   [Full Text] [Related]  

  • 4. Human T-cell lymphotropic virus infection in pregnant women in Spain.
    Tuset C; Gutiérrez M; Carbonell C; Tuset T; Soriano V
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):771-3. PubMed ID: 9405953
    [No Abstract]   [Full Text] [Related]  

  • 5. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of markers for HTLV infection among australian injecting drug users.
    Crofts N; Silvester C; Ross M
    Med J Aust; 1992 Jul; 157(1):70-1. PubMed ID: 1353605
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody to human T-lymphotropic virus type I/II (HTLV-I/II) among male inmates entering Maryland prisons.
    Vlahov D; Lee H; Taylor E; Canavaggio M; Canner C; Burczak J; Saah AJ
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):531-5. PubMed ID: 1969961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH
    BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to HTLV-1-2, HIV-1 and HIV-2 in syphilitic patients.
    Manca N; Graifenberghi S; Colombrita D
    Eur J Epidemiol; 1990 Jun; 6(2):201-6. PubMed ID: 1972926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic study of anti-HTLV-I/II antibodies in blood donors in metropolitan France. The Retrovirus Working Group of the National Blood Transfusion Society].
    Lemaire JM; Coste J; Barin F; Couroucé AM
    Rev Fr Transfus Hemobiol; 1991 Jan; 34(1):21-34. PubMed ID: 2015034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence and molecular epidemiology of human T-Cell leukemia virus type 1 (HTLV-1) and HTLV-2 in blood donors from Dakar, Senegal.
    Diop S; Calattini S; Abah-Dakou J; Thiam D; Diakhaté L; Gessain A
    J Clin Microbiol; 2006 Apr; 44(4):1550-4. PubMed ID: 16597891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of HTLV-related proviral DNA sequences and antibodies reactive with HTLV internal proteins in an Hungarian patient with Sézary syndrome.
    Kiss J; Kiss A; Tóth FD; Surányi P; Szegedi A; Rak K
    Leuk Lymphoma; 1992 Aug; 7(5-6):511-5. PubMed ID: 1362917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of antibodies to HTLV-I/II in French patients with hematological malignancies.
    Agius G; Vaillant V; Biggar RJ; Brizard A; Ranger S; Dindinaud G; Castets M
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):815-6. PubMed ID: 3145872
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroprevalence of HIV and HTLV in a representative sample of the Spanish population.
    Castilla J; Pachón I; González MP; Amela C; Muñoz L; Tello O; Noguer I; de Ory F; León P; Alonso M; Gil E; García-Sáiz A
    Epidemiol Infect; 2000 Aug; 125(1):159-62. PubMed ID: 11057971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
    Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA
    Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of HTLV-I antibody assays for HTLV-II.
    Wiktor SZ; Pate EJ; Weiss SH; Gohd RS; Correa P; Fontham ET; Hanchard B; Biggar RJ; Blattner WA
    Lancet; 1991 Aug; 338(8765):512-3. PubMed ID: 1678470
    [No Abstract]   [Full Text] [Related]  

  • 18. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.